The company, founded by UC Berkeley scientists including Jennifer Doudna, is preparing to test its lead candidate STX-1150 in ...
After a young woman develops mobility and speech issues, her grandmother seeks help from her genetic counselor, who flags a ...
Researchers will evaluate the IL1RAP-targeted nadunolimab with a checkpoint inhibitor in up to 24 metastatic microsatellite stable colorectal cancer patients.
Research conducted by Gustave Roussy will help StarkAge move STX-01, an antibody-drug conjugate targeting senescent cells, toward clinical trials.
The FDA had placed a clinical hold on Phase III trials of nex-z in ATTR-PN and ATTR-CM after a patient experienced a serious adverse event and died.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results